Bayer AG has filed patent infringement suits against Watson Laboratories, Inc. and Sandoz, Inc. due to their recent filings with the FDA for approval to market generic versions of Bayer’s Yasmin contraceptive prior to Bayer’s patent expiring.
Bayer’s patent is below as are the statements from each company:
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment